RSE

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results

Retrieved on: 
Thursday, May 11, 2023

Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the first quarter ended March 31, 2023.

Key Points: 
  • Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the first quarter ended March 31, 2023.
  • Entered exclusive distribution and supply agreement with Biologix for ganaxolone in select markets in the Middle East and North Africa.
  • Recognized $3.3 million in net product revenues for the three months ended March 31, 2023.
  • Net product revenue consists of ZTALMY product sales, which was launched in the U.S. in the third quarter of 2022.

Dr. Rodney Luster and Dr. Talee Vang to Deliver Keynote Speech for Day Two of University of Phoenix Inclusive Leadership Summit and Career Fair

Retrieved on: 
Monday, April 24, 2023

University of Phoenix is pleased to announce Dr. Rodney Luster and Dr. Talee Vang as the keynote speakers for the second day of the University’s annual Inclusive Leadership Summit and Career Fair, May 2-4, 2023 .

Key Points: 
  • University of Phoenix is pleased to announce Dr. Rodney Luster and Dr. Talee Vang as the keynote speakers for the second day of the University’s annual Inclusive Leadership Summit and Career Fair, May 2-4, 2023 .
  • Throughout this session, there will be opportunities to discuss how these challenges disproportionately impact workplaces, schools, the healthcare system, and other social settings.
  • Participants will leave with practical resources to put inclusive leadership skills into practice and a greater understanding of potential impact.
  • Participants will engage in facilitated conversations about workforce trends and learn the skills necessary to become effective inclusive leaders in the workplace.

EQS-News: HOUSING WITH A VISION: TAG IMMOBILIEN AG PUBLISHES SUSTAINABILITY REPORT 2022

Retrieved on: 
Thursday, April 20, 2023

ESG targets implemented in LTIP for management board; Olaf Borkers to be put up for vote as new member of the supervisory board

Key Points: 
  • ESG targets implemented in LTIP for management board; Olaf Borkers to be put up for vote as new member of the supervisory board
    TAG Immobilien AG (TAG) today published its eleventh sustainability report.
  • This report supplements and complements the financial reporting in the annual report published on 16 March 2023 with all material non-financial aspects of the 2022 financial year.
  • With the sustainability report 2022, we reflect on our sustainability ambitions and vision until 2045, as defined by a concrete set of measures and interim targets.
  • In the past 20 years, he has worked in various senior positions at Deutsche Bank AG, RSE Grundbesitz- und Beteiligungs AG, TAG Immobilien AG (CFO position) and, most recently, Deutsche EuroShop AG (CEO and CFO position).

Tackling online misogyny: what needs to be done in schools – and our communities

Retrieved on: 
Tuesday, April 4, 2023

One-third of young people have reported receiving nude videos or photographs, with more than half sent from strangers.

Key Points: 
  • One-third of young people have reported receiving nude videos or photographs, with more than half sent from strangers.
  • Access to this online material has been linked by teachers to increases in sexual assault and misogynistic behaviour.
  • Improving communication between schools and families is crucial so that messaging and advice about online misogyny is consistent.

On the curriculum

    • Events such as Safer Internet Day can do good work in schools.
    • There is not the space in the current national curriculum to examine and critique online misogyny in the detail it desperately needs.
    • It’s not just in RSE, but across the curriculum that misogyny should be addressed.
    • This presents an opportunity to make the problem of online misogyny more prominent and change the way it is taught.

Many ways to be a man

    • These alternative ways of performing masculinities need to be taught in schools, so that the simplistic ways social influencers act out extreme masculinities online can be critiqued and replaced with knowledge of healthier identities and relationships.
    • Organisations such as Beyond Equality run male-led workshops in schools to rethink dominant, macho masculinity.
    • Students unpick stereotypes and are taught different ways of performing masculinities.
    • At a primary school level, there is a lack of male teachers who can act as positive role models.

Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Tuesday, March 7, 2023

Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2022.

Key Points: 
  • Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2022.
  • “2022 was a year of significant growth and execution for Marinus, underscored by the successful U.S. launch of ZTALMY,” said Scott Braunstein, M.D., Chairman and Chief Executive Officer of Marinus.
  • Recognized $2.3 million and $2.9 million in net product revenues for the three and twelve months ended December 31, 2022, respectively.
  • Recognized collaboration revenue of $3.0 million in the fourth quarter of 2022 related to the upfront payment associated with the Company’s development and commercialization agreement with Tenacia.

University of Phoenix College of Doctoral Studies Hosts Record Number of Attendees at Knowledge Without Boundaries Summit

Retrieved on: 
Wednesday, November 30, 2022

University of Phoenix College of Doctoral Studies welcomed more than 560 attendees, the largest number to date, during the annual Knowledge Without Boundaries Summit, held October 13-15, 2022.

Key Points: 
  • University of Phoenix College of Doctoral Studies welcomed more than 560 attendees, the largest number to date, during the annual Knowledge Without Boundaries Summit, held October 13-15, 2022.
  • The Knowledge Without Boundaries Summit welcomed 280 students this year, our largest student demographic to date, states Hinrich Eylers, Ph.D., P.E., vice provost, College of Doctoral Studies.
  • Jacobs is Professor Emeritus at Ohio State University and a professor of human resource development at the University of Illinois at Urbana-Champaign.
  • The Journal of Leadership Studies is a quarterly academic research publication, produced by Wiley, on behalf of the University of Phoenix College of Doctoral Studies.

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 7, 2022

Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the third quarter ended September 30, 2022.

Key Points: 
  • Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the third quarter ended September 30, 2022.
  • We believe we are poised to execute on our goals and expand our reach to additional patients suffering from rare forms of epilepsy.
  • Collaboration revenue in 2022 consists of a one-time revenue recognition of $12.7 million in the first quarter of 2022 related to the Orion collaboration.
  • The Company reported net income of $73.3 million and $14.5 million for the three and nine months ended September 30, 2022, respectively.

University of Phoenix College of Doctoral Studies Announces Annual Knowledge Without Borders Summit

Retrieved on: 
Friday, October 7, 2022

University of Phoenix College of Doctoral Studies will hold its annual research event, Knowledge Without Borders Summit, on October 13-15, 2022, Moving Forward: Bridging the Gap Between Practice, Belonging, and Community, with topics exploring the potential of how society can catalyze forward after a confluence of events.

Key Points: 
  • University of Phoenix College of Doctoral Studies will hold its annual research event, Knowledge Without Borders Summit, on October 13-15, 2022, Moving Forward: Bridging the Gap Between Practice, Belonging, and Community, with topics exploring the potential of how society can catalyze forward after a confluence of events.
  • The Knowledge Without Borders Summit convenes our scholars faculty, students, new graduates, and alumni, and provides a space for them to enrich and enlighten each other, states Hinrich Eylers, Ph.D., P.E., vice provost, College of Doctoral Studies.
  • The Journal of Leadership Studies is a quarterly academic research publication, produced by Wiley, on behalf of the University of Phoenix College of Doctoral Studies.
  • University of Phoenixs College of Doctoral Studies focuses on todays challenging business and organizational needs, from addressing critical social issues to developing solutions to accelerate community building and industry growth.

Marinus Pharmaceuticals Announces Exercise of First Contract Option by the Biomedical Advanced Research and Development Authority (BARDA)

Retrieved on: 
Thursday, September 22, 2022

This contract option was exercised under Marinus ongoing cost-share contract with BARDA awarded in 2020 to support the development of intravenous (IV) ganaxolone for the treatment of refractory status epilepticus (RSE).

Key Points: 
  • This contract option was exercised under Marinus ongoing cost-share contract with BARDA awarded in 2020 to support the development of intravenous (IV) ganaxolone for the treatment of refractory status epilepticus (RSE).
  • Refractory status epilepticus is a life-threatening condition in which a significant number of patients do not respond to first- and second-line anticonvulsant drugs.
  • Ganaxolone development in the RAISE trial is being funded in part with federal funds from BARDA under contract number 75A50120C00159.
  • Any forward-looking statements that we make in this press release speak only as of the date of this press release.

Velocity Capital Management Launches as an Investment Firm Focusing on the Sports, Media, and Entertainment Ecosystem

Retrieved on: 
Tuesday, September 20, 2022

NEW YORK, Sept. 20, 2022 /PRNewswire/ -- Velocity Capital Management ("Velocity") launched today as an investment firm that collaborates with visionary founders and executive teams to build best-in-class global businesses at the intersection of sports, media, and entertainment. With more than 60 years of relevant and collective experience, Co-Founders David Abrams and Arne Rees have significant domain expertise as investors, owners, and operators of professional sports and esports franchises, sports betting, data and analytics businesses, and digital entertainment and content production companies.

Key Points: 
  • Velocity's investment philosophy is anchored by three pillars: capital preservation, rigorous diligence, and a focus on delivering attractive risk-adjusted returns.
  • Mr. Zane worked on numerous acquisitions, capital raises, and financing transactions throughout the sports and entertainment ecosystem at Evolution Media Capital.
  • Velocity Capital Managementis an investment firm that collaborates with visionary founders and executive teams to build the next generation of best-in-class global businesses at the intersection of sports,media, and entertainment.
  • We combine this investment acumen with our domain expertise gained through ownership and operational roles across the sports, media, and entertainment ecosystem.